Pregled bibliografske jedinice broj: 538796
Different effects of phosphatidylinositol 3-kinase inhibitor LY294002 and Akt inhibitor SH-5 on cell cycle progression in synchronized HL-60 leukemia cells
Different effects of phosphatidylinositol 3-kinase inhibitor LY294002 and Akt inhibitor SH-5 on cell cycle progression in synchronized HL-60 leukemia cells // Periodicum biologorum, 113 (2011), 61-67 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 538796 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Different effects of phosphatidylinositol 3-kinase inhibitor LY294002 and Akt inhibitor SH-5 on cell cycle progression in synchronized HL-60 leukemia cells
Autori
Lukinović-Škudar, Vesna ; Banfić, Hrvoje ; Višnjić, Dora
Izvornik
Periodicum biologorum (0031-5362) 113
(2011);
61-67
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
cell cycle; phosphatidylinositol 3-kinase; protein kinase B/Akt; inhibitor; HL-60
Sažetak
Background and Purpose: Pharmacological inhibitors of phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway have been proposed in treatment of leukemia. Our previous studies demonstrated that PI3K inhibitor LY294002 and Akt inhibitor SH-5 reduced the number of viable HL-60 leukemia cells, but exerted different effects on their differentiation. PI3K inhibitor LY294002 induced an arrest of HL-60 cells in G0/G1 and G2/M phases of the cell cycle, but the effects of Akt inhibitor on cell cycle progression have not been investigated. The present study was undertaken in order to compare the effects of LY294002 and SH-5 on cell cycle progression in a model of aphidicolin and nocodazole-synchronized HL-60 cells. Materials and Methods: HL-60 cells were arrested at G1/S phase by aphidicolin, or G2/M phase by nocodazole, washed and allowed to progress synchronously through the cell cycle. PI3K inhibitor LY294002 (10 M) and Akt inhibitor SH-5 (20 M) were added to medium after release from the block. DNA content was determined by propidium iodide staining and flow cytometry. Results: In aphidicolin-synchronized HL-60 cells, LY294002 induced a delay in progression through S and G2/M phases, while Akt inhibitor had no significant effects. No statistically significant effects were observed in LY294002 or SH-5-treated cells at 1-5 h after release from nocodazole block. Conclusion: PI3K inhibitor LY294002 and Akt inhibitor SH-5, applied at doses that effectively inhibit Akt-activity, have different effects on cell cycle progression in aphidicolin-synchronized HL-60 cells, suggesting that LY294002-induced delay in S and G2/M phase is probably not due to the specific inhibition of Akt-activity.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
108-1081347-0173 - Funkcija fosfoinozitol 3-kinaze C2 beta u staničnim jezgrama (Banfić, Hrvoje, MZOS ) ( CroRIS)
108-1081347-1448 - Uloga PLC i Akt u staničnom ciklusu i diferencijaciji leukemija (Višnjić, Dora, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- SCI-EXP, SSCI i/ili A&HCI